Relationship between TP73 polymorphism (G4C14-A4T14) and cancer risk: A meta-analysis based on literatures

Gene

Volumn 484, Issue 1-2, 2011, Pages 42-46

  Yu, Xiao Jia ^a   Fang, Fang ^a   Xie, Jun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Cancer risk; G4C14 A4T14; Meta analysis; Polymorphism; TP73

Indexed keywords

PROTEIN P73;

APOPTOSIS; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CAUCASIAN; CELL CYCLE ARREST; COLORECTAL CANCER; CONTROLLED STUDY; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MEDICAL LITERATURE; MELANOMA; MOUTH CANCER; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; OVARY CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; UTERINE CERVIX CANCER;

DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; RISK FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 79960939739     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.05.022     Document Type: Article

References (32)

1. Ahomadegbe J.C., Tourpin S., Kaghad M., Zelek L., Vayssade M., Mathieu M.C., et al. Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers. Oncogene 2000, 19:5413-5418. [PubMed: 11103943].
2. Arfaoui A.T., Kriaa L.B., El Hadj Oel A., Ben Hmida M.A., Khiari M., Khalfallah T., et al. Association of a p73 exon 2 GC/AT polymorphism with colorectal cancer risk and survival in Tunisian patients. Virchows Arch. 2010, 457:359-368. [PubMed: 20644956].
3. Chen X., Sturgis E.M., El-Naggar A.K., Wei Q., Li G. Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers. Carcinogenesis 2008, 29:2120-2125. [PubMed: 18701437].
4. Choi J.E., Kang H.G., Chae M.H., Kim E.J., Lee W.K., Cha S.I., et al. No association between p73 G4C14-to-A4T14 polymorphism and the risk of lung cancer in a Korean population. Biochem. Genet. 2006, 44:543-550. [PubMed: 17136456].
5. De Feo E., Persiani R., La Greca A., Amore R., Arzani D., Rausei S., et al. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression. Mutat. Res. 2009, 675:60-65. [PubMed: 19386249].
6. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-188. [PubMed: 3802833].
7. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634. [PubMed: 9310563].
8. Ge H., Wang Y.M., Cao Y.Y., Zhang X.F., Li Y., Guo W., et al. Correlation of p73 polymorphisms to genetic susceptibilities to esophageal carcinoma and gastric cardiac carcinoma. Ai Zheng 2006, 25:1351-1355. [PubMed: 17094900].
9. Ge H., Wang Y.M., Cao Y.Y., Chen Z.F., Wen D.G., Guo W., et al. The p73 polymorphisms are not associated with susceptibility to esophageal squamous cell carcinoma in a high incidence region of China. Dis. Esophagus 2007, 20:290-296. [PubMed: 17617876].
10. Hamajima N., Matsuo K., Suzuki T., Nakamura T., Matsuura A., Hatooka S., et al. No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Lett. 2002, 181:81-85. [PubMed: 12430182].
11. Hiraki A., Matsuo K., Hamajima N., Ito H., Hatooka S., Suyama M., et al. Different risk relations with smoking for non-small-cell lung cancer: comparison of TP53 and TP73 genotypes. Asian Pac. J. Cancer Prev. 2003, 4:107-112. [PubMed: 12875622].
12. Hishida A., Matsuo K., Tajima K., Ogura M., Kagami Y., Taji H., et al. Polymorphisms of p53 Arg72Pro, p73 G4C14-to-A4T14 at exon 2 and p21 Ser31Arg and the risk of non-Hodgkin's lymphoma in Japanese. Leuk. Lymphoma 2004, 45:957-964. [PubMed: 15291355].
13. Hu Z., Miao X., Ma H., Tan W., Wang X., Lu D., et al. Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population. Int. J. Cancer 2005, 114:455-460. [PubMed: 15578704].
14. Hu Z.B., Miao X.P., Ma H.X., Tan W., Niu J.Y., Lin D.X., et al. Association of two genetic polymorphisms in the 5'untranslated region of exon 2 of the p73 gene and risk of lung cancer. Zhonghua Liu Xing Bing Xue Za Zhi 2005, 26:106-109. [PubMed: 15921610].
15. Huang X.E., Hamajima N., Katsuda N., Matsuo K., Hirose K., Mizutani M., et al. Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer. Breast Cancer 2003, 10:307-311. [PubMed: 14634508].
16. Jost C.A., Marin M.C., Kaelin W.G. p73 is a simian p53-related protein that can induce apoptosis. Nature 1997, 389:191-194. [PubMed: 9296498].
17. Jun H.J., Park S.H., Lee W.K., Choi J.E., Jang J.S., Kim E.J., et al. Combined effects of p73 and MDM2 polymorphisms on the risk of lung cancer. Mol. Carcinog. 2007, 46:100-105. [PubMed: 17013834].
18. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J.C., Valent A., et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997, 90:809-819. [PubMed: 9288759].
19. Kang S., Wang D.J., Li W.S., Wang N., Zhou R.M., Sun D.L., et al. Association of p73 and MDM2 polymorphisms with the risk of epithelial ovarian cancer in Chinese women. Int. J. Gynecol. Cancer 2009, 19:572-577. [PubMed: 19509552].
20. Lau J., Ioannidis J.P., Schmid C.H. Quantitative synthesis in systematic reviews. Ann. Intern. Med. 1997, 127:820-826. [PubMed: 9382404].
21. Lee K.E., Hong Y.S., Kim B.G., Kim N.Y., Lee K.M., Kwak J.Y., et al. p73 G4C14 to A4T14 polymorphism is associated with colorectal cancer risk and survival. World J. Gastroenterol. 2010, 16:4448-4454. [PubMed: 20845513].
22. Li G., Sturgis E.M., Wang L.E., Chamberlain R.M., Amos C.I., Spitz M.R., et al. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis 2004, 25:1911-1916. [PubMed: 15180941].
23. Li G., Wang L.E., Chamberlain R.M., et al. p73 G4C14-to-A4T14 polymorphism and risk of lung cancer. Cancer Res. 2004, 64:6863-6866. [PubMed: 15466174].
24. Li C., Chen K., Liu Z., Wang L.E., Gershenwald J.E., Lee J.E., et al. Polymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma. J. Invest. Dermatol. 2008, 128:1585-1588. [PubMed: 18049450].
25. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748. [PubMed: 13655060].
26. Melino G., De Laurenzi V., Vousden K.H. p73: friend or foe in tumorigenesis. Nat. Rev. Cancer 2002, 2:605-615. [PubMed: 12154353].
27. Misra C., Majumder M., Bajaj S., Ghosh S., Roy B., Roychoudhury S. Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer. Mol. Carcinog. 2009, 48:790-800. [PubMed: 19204927].
28. Niwa Y., Hamajima N., Atsuta Y., Yamamoto K., Tamakoshi A., Saito T., et al. Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese. Cancer Lett. 2004, 205:55-60. [PubMed: 15036661].
29. Niwa Y., Hirose K., Matsuo K., Tajima K., Ikoma Y., Nakanishi T., et al. Association of p73 G4C14-to-A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects. Cancer Lett. 2005, 219:183-190. [PubMed: 15723718].
30. Pfeifer D., Arbman G., Sun X.F. Polymorphism of the p73 gene in relation to colorectal cancer risk and survival. Carcinogenesis 2005, 26:103-107. [PubMed: 15485994].
31. Romani M., Scaruffi P., Casciano I., Mazzocco K., Lo Cunsolo C., Cavazzana A., et al. Stage-independent expression and genetic analysis of tp73 in neuroblastoma. Int. J. Cancer 1999, 84:365-369. [PubMed: 10404087].
32. Ryan B.M., McManus R., Daly J.S., Carton E., Keeling P.W., Reynolds J.V., et al. A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma. Br. J. Cancer 2001, 85:1499-1503. [PubMed: 11720435].